Article thumbnail

Clinical features and multidisciplinary approaches to dementia care

By Jacob HG Grand, Sienna Caspar and Stuart WS MacDonald


Dementia is a clinical syndrome of widespread progressive deterioration of cognitive abilities and normal daily functioning. These cognitive and behavioral impairments pose considerable challenges to individuals with dementia, along with their family members and caregivers. Four primary dementia classifications have been defined according to clinical and research criteria: 1) Alzheimer’s disease; 2) vascular dementias; 3) frontotemporal dementias; and 4) dementia with Lewy bodies/Parkinson’s disease dementia. The cumulative efforts of multidisciplinary healthcare teams have advanced our understanding of dementia beyond basic descriptions, towards a more complete elucidation of risk factors, clinical symptoms, and neuropathological correlates. The characterization of disease subtypes has facilitated targeted management strategies, advanced treatments, and symptomatic care for individuals affected by dementia. This review briefly summarizes the current state of knowledge and directions of dementia research and clinical practice. We provide a description of the risk factors, clinical presentation, and differential diagnosis of dementia. A summary of multidisciplinary team approaches to dementia care is outlined, including management strategies for the treatment of cognitive impairments, functional deficits, and behavioral and psychological symptoms of dementia. The needs of individuals with dementia are extensive, often requiring care beyond traditional bounds of medical practice, including pharmacologic and non-pharmacologic management interventions. Finally, advanced research on the early prodromal phase of dementia is reviewed, with a focus on change-point models, trajectories of cognitive change, and threshold models of pathological burden. Future research goals are outlined, with a call to action for social policy initiatives that promote preventive lifestyle behaviors, and healthcare programs that will support the growing number of individuals affected by dementia

Topics: Review
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results.
  2. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer’s disease. Stat Med.
  3. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?
  4. (2010). A theoretical framework for the study of adult cognitive plasticity. Psychol Bull.
  5. (2003). Alzheimer disease and other dementias. Clin Geriatr Med.
  6. Alzheimer’s and non-alzheimer’s dementia: a critical review of pharmacological and nonpharmacological strategies.
  7. (2008). Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol.
  8. Alzheimer’s disease: the amyloid cascade hypothesis.
  9. Alzheimer’s disease.
  10. (2004). An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol.
  11. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging.
  12. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
  13. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease.
  14. (2010). Assessing the progression of mild cognitive impairment to Alzheimer’s disease: current trends and future directions. Alzheimers Res Ther.
  15. (2001). Behavior and treatment in frontotemporal dementia.
  16. (2003). Behavioral and psychologic symptoms of dementia. Clin Geriatr Med.
  17. (2009). Behavioral and psychological symptoms of dementia and medical treatment.
  18. Behavioral symptoms in mild cognitive impairment.
  19. Behavioral treatment of depression in dementia patients: a controlled clinical trial.
  20. Behavioural and psychological syndromes in Alzheimer’s disease.
  21. (2005). Behavioural symptoms of dementia in residential settings: a selective review of non-pharmacological interventions. Aging Ment Health.
  22. (2004). Beyond memory: neuropsychologic features in differential diagnosis of dementia. Clin Geriatr Med.
  23. (2006). Brain imaging evidence of preclinical Alzheimer’s disease in normal aging. Ann Neurol.
  24. Caregivers’ reasons for nursing home placement: clues for improving discussions with families prior to the transition.
  25. (2009). Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementiacare mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol.
  26. Carl Rogers’ Life and Work: An Assessment on the 100th Anniversary of His Birth.
  27. (2006). Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev.
  28. (2001). Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol.
  29. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA
  30. (1994). Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol.
  31. (2008). cognitive decline and dementia. Arch Cardiovasc Dis.
  32. Cognitive functioning in Alzheimer’s disease and vascular dementia: further evidence for similar patterns of deficits.
  33. (2005). Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis.
  34. (1997). Cognitive predictors of incident Alzheimer’s disease: a prospective longitudinal study.
  35. (2003). Cognitive rehabilitation and cognitive training for early-stage Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev.
  36. (2007). Cognitive Reserve: Theory and Applications.
  37. (1999). Community formation and community roles among persons with Alzheimer’s disease: a comparative study of experiences in a residential Alzheimer’s facility and a traditional nursing home. Qual Health Res.
  38. Components of behavioral pathology in dementia.
  39. (2003). Conducting research on home environments: lessons learned and new directions.
  40. Confabulation and memory in patients with Alzheimer’s disease.
  41. Current concepts in Alzheimer’s disease: a multidisciplinary review.
  42. Deciding on institutionalization for a relative with dementia: the most difficult decision for caregivers.
  43. (2002). Defining dementia: clinical criteria for the diagnosis of vascular dementia. Acta Neurol Scand Suppl.
  44. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations.
  45. (2007). Dementia with Lewy bodies. Handb Clin Neurol.
  46. (2006). Dementia: a brief review.
  47. (2009). Dementia: the bare essentials. Pract Neurol.
  48. Detection of Alzheimer’s disease and dementia in the preclinical phase: population based cohort study.
  49. Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach.
  50. Diagnosis and biomarkers of predementia in Alzheimer’s disease.
  51. Diagnosis and management of dementia with Lewy bodies:
  52. (2008). Diagnosis and treatment of dementia with Lewy bodies.
  53. (2004). Diagnosis and treatment of depression in Alzheimer’s disease. A practical update for the clinician. Dement Geriatr Cogn Disord.
  54. (2000). Diagnostic and statistical manual of mental disorders.
  55. (2008). Diagnostic criteria of vascular dementia in
  56. (2009). Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr.
  57. (2002). Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer’s disease. Clin Neuropsychol.
  58. (2009). Different risk factors in vascular dementia and ischaemic stroke. Neuroepidemiology.
  59. (2004). Differential diagnosis of dementia syndromes. Clin Geriatr Med.
  60. (2002). Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am
  61. (2007). Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer’s disease.
  62. (2006). Distinguishing Different Dementias. Canadian Review of Alzheimer’s Disease and Other Dementias.
  63. Does late-life physical activity or exercise prevent or minimize disablement? A critical review of the scientific evidence.
  64. Does participation in leisure activities lead to reduced risk of Alzheimer’s disease? A prospective study of Swedish twins.
  65. Donepezil in patients with severe Alzheimer’s disease: double-blind, parallel-group, placebocontrolled study.
  66. Early community-based service utilization and its effects on institutionalization in dementia caregiving.
  67. Education delays accelerated decline on a memory test in persons who develop dementia.
  68. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
  69. Effect of music therapy on anxiety and depression in patients with Alzheimer’s type dementia: randomised, controlled study. Dement Geriatr Cogn Disord.
  70. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord.
  71. (1998). Environmental correlates of resident agitation in Alzheimer’s disease special care units. J Am Geriatr Soc.
  72. (2003). Environmental correlates to behavioral health outcomes in Alzheimer’s special care units.
  73. Epidemiological studies of the effect of stroke on incident dementia: a systematic review.
  74. (2009). Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci.
  75. Episodic memory functioning in a community-based sample of old adults with major depression: utilization of cognitive support.
  76. (2001). Exercise dose-response effects on quality of life and independent living in older adults. Med Sci Sports Exerc.
  77. experience and the aging brain. Neurobiol Aging.
  78. (2007). Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement.
  79. From the Centers for Disease Control and Prevention. Public health and aging: trends in aging – United States and worldwide.
  80. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord.
  81. (2007). Frontotemporal dementia. Semin Neurol.
  82. (1998). Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
  83. (2007). Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol.
  84. Global prevalence of dementia: a Delphi consensus study.
  85. (2005). Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry.
  86. (2010). Hypertension is a potential risk factor for vascular dementia: systematic review.
  87. (2008). Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol.
  88. Impaired financial abilities in mild cognitive impairment: a direct assessment approach.
  89. (2002). Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging.
  90. Interdisciplinary approaches to Alzheimer’s disease management.
  91. (2002). Interventions for family members caring for an elder with dementia. Annu Rev Nurs Res.
  92. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials.
  93. (2009). Is there a neuropathology difference between mild cognitive impairment and dementia? Dialogues Clin Neurosci.
  94. (2006). Keep music live: music and the alleviation of apathy in dementia subjects. Int Psychogeriatr.
  95. (2005). Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol.
  96. (2001). Long-term care and a good quality of life: bringing them closer together.
  97. Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr.
  98. (2010). Management of inappropriate sexual behaviors in dementia: a literature review. Int Psychogeriatr.
  99. (2002). measures and approaches to easing caregiver burden in Alzheimer’s disease. Drugs Aging.
  100. (2008). Memory and cognitive performance in preclinical Alzheimer’s Disease and preclinical Vascular Disease. In:
  101. (1998). Memory change in the aged. New York:
  102. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer’s disease.
  103. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med.
  104. (2008). Mild cognitive impairment: a concept ready to move on? Curr Opin Psychiatry.
  105. (2008). Mild cognitive impairment: a neuropsychological perspective. CNS Spectr.
  106. Mild cognitive impairment.
  107. Mobius HJ. Memantine in moderate-to-severe Alzheimer’s disease.
  108. (2006). Music therapy in moderate and severe dementia of Alzheimer’s type: a case-control study. Int Psychogeriatr.
  109. Need-driven dementia-compromised behavior: an alternative view of disruptive behavior.
  110. neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
  111. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis.
  112. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer’s disease. Acta Neurol Scand Suppl.
  113. (2007). Neuropsychological testing and assessment for dementia. Alzheimers Dement.
  114. (2009). Non-pharmacological management of behavioural symptoms in nursing homes. Int J Geriatr Psychiatry.
  115. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique.
  116. Onset and rate of cognitive change before dementia diagnosis: findings from two Swedish population-based longitudinal studies.
  117. (2006). Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dement Geriatr Cogn Disord.
  118. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry.
  119. Patterns of cognitive impairment in Alzheimer’s disease: assessment and differential diagnosis. Front Biosci.
  120. (2003). Person-centered care. An important approach for 21st century health care. J Psychosoc Nurs Ment Health Serv.
  121. (2008). Person-centred care of people with severe Alzheimer’s disease: current status and ways forward. Lancet Neurol.
  122. (2005). Physical activity and psychological well-being in advanced age: a meta-analysis of intervention studies. Psychol Aging.
  123. (2008). Physical activity programs for persons with dementia. Cochrane Database Syst Rev.
  124. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry.
  125. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review).
  126. Predictors of institutionalization among caregivers of patients with Alzheimer’s disease.
  127. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts.
  128. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
  129. Preventable senility: a call for action against the vascular dementias.
  130. (1987). Progressively lowered stress threshold: a conceptual model for care of adults with Alzheimer’s disease. Arch Psychiatr Nurs.
  131. Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat.
  132. Prospects for the prevention of dementia.
  133. Psychiatric symptoms vary with the severity of dementia in probable Alzheimer’s disease.
  134. (2006). psychological and physical symptoms in group homes for older adults with dementia. Int Psychogeriatr.
  135. Rate of cognitive decline in preclinical Alzheimer’s disease: the role of comorbidity.
  136. (2005). Reminiscence therapy for dementia. Cochrane Database Syst Rev.
  137. (2007). Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol.
  138. (1985). Revised Ischemic Score for diagnosing multi-infarct dementia. J Clin Psychiatry.
  139. (2006). Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry.
  140. (2004). Similar early clinical presentations in familial and non-familial frontotemporal dementia. J Neurol Neurosurg Psychiatry.
  141. (2010). Society. Rising Tide: The Impact of Dementia on Canadian Society.
  142. (2009). Stroke and dementia. Neurol Res.
  143. Subcortical ischemic vascular dementia.
  144. (2009). Symbolic meaning of relocation to a residential care facility for persons with dementia. Aging Ment Health.
  145. (2010). Syndromic association of behavioral and psychological symptoms of dementia in Alzheimer disease and patient classification. Am J Geriatr Psychiatry.
  146. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life.
  147. (2000). The effects of physical training of functional capacity in adults.
  148. (2004). The family’s role in person-centered care: practice considerations. J Psychosoc Nurs Ment Health Serv.
  149. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord.
  150. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease.
  151. (2010). The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr.
  152. The neuropsychological profiles of mild Alzheimer’s disease and questionable dementia as compared to age-related cognitive decline.
  153. The prevalence of frontotemporal dementia.
  154. (2003). The process of mediated aging-in-place: a theoretically and empirically based model. Soc Sci Med.
  155. (2003). The role of cerebrovascular disease in dementia.
  156. The staging and assessment of moderate to severe Alzheimer disease.
  157. (2009). Top cited papers in International Psychogeriatrics: 4. Effects of individualized vs classical “relaxation” music on the frequency of agitation in elderly persons with Alzheimer’s disease and related disorders. Int Psychogeriatr.
  158. (2000). Treating dementia: the complementing team approach of occupational therapy and psychology.
  159. (2009). Understanding white matter disease: imagingpathological correlations in vascular cognitive impairment.
  160. (2010). Update on frontotemporal dementia.
  161. Using a biopsychosocial model of dementia as a tool to guide clinical practice.
  162. (2003). Validation therapy for dementia. Cochrane Database Syst Rev.
  163. Vascular dementia may be the most common form of dementia in the elderly.
  164. Vascular dementia: diagnostic criteria for research studies.
  165. (2007). Vascular dementia: emerging trends. Semin Neurol.
  166. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints.
  167. (2002). Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
  168. vitamins, cognition, and aging: a review.
  169. (2006). What best differentiates Lewy body from Alzheimer’s disease in early-stage dementia?
  170. (2010). Whole brain atrophy rate predicts progression from MCI to Alzheimer’s disease. Neurobiol Aging.